Noninvasive fractional flow on MRA predicts stroke risk of intracranial stenosis.

Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol (2013) 1.23

Evaluating intracranial atherosclerosis rather than intracranial stenosis. Stroke (2014) 0.92

Magnetic resonance angiography signal intensity as a marker of hemodynamic impairment in intracranial arterial stenosis. PLoS One (2013) 0.89

Developing precision stroke imaging. Front Neurol (2014) 0.88

Fractional Flow in Cerebrovascular Disorders. Interv Neurol (2013) 0.88

Imaging of cerebrovascular disorders: precision medicine and the collaterome. Ann N Y Acad Sci (2015) 0.84

The Feinberg Award Lecture 2013: treatment of intracranial atherosclerosis: learning from the past and planning for the future. Stroke (2013) 0.82

Stroke Caused by Atherosclerosis of the Major Intracranial Arteries. Circ Res (2017) 0.81

Relationship between visible branch arteries distal to the stenosis on magnetic resonance angiography and stroke recurrence in patients with severe middle cerebral artery trunk stenosis: a one-year follow up study. BMC Neurol (2015) 0.81

Emerging techniques for evaluation of the hemodynamics of intracranial vascular pathology. Neuroradiol J (2015) 0.75

Fractional Flow Assessment for the Evaluation of Intracranial Atherosclerosis: A Feasibility Study. Interv Neurol (2016) 0.75

Local blood pressure associates with the degree of luminal stenosis in patients with atherosclerotic disease in the middle cerebral artery. Biomed Eng Online (2016) 0.75

Mismatch between TOF MR Angiography and CT Angiography of the Middle Cerebral Artery may be a Critical Sign in Cerebrovascular Dynamics. Yonsei Med J (2018) 0.75

Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med (2009) 13.42

Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med (2011) 12.76

Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med (2012) 8.39

Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med (2005) 7.92

Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet (2011) 7.50

Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med (1996) 5.93

Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms. Results from the prospective multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve) study. J Am Coll Cardiol (2011) 4.96

Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation (2006) 4.21

The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology (2007) 3.24

Usefulness of noninvasive fractional flow reserve computed from coronary computed tomographic angiograms for intermediate stenoses confirmed by quantitative coronary angiography. Am J Cardiol (2012) 1.24

Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. J Am Coll Cardiol (2005) 1.22

Comparison between visual assessment and quantitative angiography versus fractional flow reserve for native coronary narrowings of moderate severity. Am J Cardiol (2002) 1.15

Signal intensity ratio as a novel measure of hemodynamic significance for intracranial atherosclerosis. Int J Stroke (2013) 0.94

Interobserver reproducibility of signal intensity ratio on magnetic resonance angiography for hemodynamic impact of intracranial atherosclerosis. J Stroke Cerebrovasc Dis (2013) 0.90

Evaluation of functional severity of coronary artery disease and fluid dynamics' influence on hemodynamic parameters: A review. Phys Med (2012) 0.87

Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med (2011) 12.76

Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med (2015) 8.70

Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med (2005) 7.92

Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 7.48

Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet (2009) 6.82

Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke (2009) 6.62

Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke (2007) 5.55

Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation (2006) 4.21

A randomized clinical trial comparing contact lens with intraocular lens correction of monocular aphakia during infancy: grating acuity and adverse events at age 1 year. Arch Ophthalmol (2010) 4.12

Comparison of contact lens and intraocular lens correction of monocular aphakia during infancy: a randomized clinical trial of HOTV optotype acuity at age 4.5 years and clinical findings at age 5 years. JAMA Ophthalmol (2014) 3.88

Risk assessment for ectasia after corneal refractive surgery. Ophthalmology (2007) 3.47

The infant aphakia treatment study: design and clinical measures at enrollment. Arch Ophthalmol (2010) 3.21

Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry (2011) 3.15

Effects of nurse-managed protocols in the outpatient management of adults with chronic conditions: a systematic review and meta-analysis. Ann Intern Med (2014) 2.82

Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis (2011) 2.70

Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol (2011) 2.62

Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. JAMA (2002) 2.58

The resident surgeon phacoemulsification learning curve. Arch Ophthalmol (2007) 2.57

Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation (2007) 2.50

Complications, adverse events, and additional intraocular surgery 1 year after cataract surgery in the infant Aphakia Treatment Study. Ophthalmology (2011) 2.49

Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation (2007) 2.44

Thoracoscopic lobectomy has increasing benefit in patients with poor pulmonary function: a Society of Thoracic Surgeons Database analysis. Ann Surg (2012) 2.33

Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Radic Biol Med (2002) 2.22

Long-term risk of glaucoma after congenital cataract surgery. Am J Ophthalmol (2013) 2.22

Predictability of intraocular lens power calculation formulae in infantile eyes with unilateral congenital cataract: results from the Infant Aphakia Treatment Study. Am J Ophthalmol (2013) 2.20

Congruency in homonymous hemianopia. Am J Ophthalmol (2007) 2.17

One-year strabismus outcomes in the Infant Aphakia Treatment Study. Ophthalmology (2013) 2.00

Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke (2012) 1.91

Intracranial atherosclerotic disease: an update. Ann Neurol (2009) 1.86

Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. Am J Public Health (2012) 1.82

Gender differences in outcomes among patients with symptomatic intracranial arterial stenosis. Stroke (2007) 1.81

Lymph node evaluation by open or video-assisted approaches in 11,500 anatomic lung cancer resections. Ann Thorac Surg (2012) 1.74

Endovascular treatment for acute ischemic stroke--still unproven. N Engl J Med (2013) 1.68

Review of corneal endothelial specular microscopy for FDA clinical trials of refractive procedures, surgical devices, and new intraocular drugs and solutions. Cornea (2008) 1.68

Morphological clustering and analysis of continuous intracranial pressure. IEEE Trans Biomed Eng (2008) 1.67

Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review. Ann Intern Med (2014) 1.67

Management strategies for asymptomatic carotid stenosis: a systematic review and meta-analysis. Ann Intern Med (2013) 1.67

Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women. Stroke (2002) 1.63

Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial. Circ Cardiovasc Qual Outcomes (2012) 1.63

Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Neurosurgery (2013) 1.58

Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis. Stroke (2009) 1.54

Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists. Cerebrovasc Dis (2014) 1.51

Is there a latent period for the surgical treatment of children with dense bilateral congenital cataracts? J AAPOS (2006) 1.48

Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial. J Neurointerv Surg (2012) 1.45

RR-interval irregularity precedes ventricular fibrillation in ST elevation acute myocardial infarction. Heart Rhythm (2009) 1.42

Asymptomatic carotid artery stenosis treated with medical therapy alone: temporal trends and implications for risk assessment and the design of future studies. Cerebrovasc Dis (2014) 1.42

Infant Aphakia Treatment Study: effects of persistent fetal vasculature on outcome at 1 year of age. J AAPOS (2011) 1.40

Predictors of anastomotic leak after esophagectomy: an analysis of the society of thoracic surgeons general thoracic database. Ann Thorac Surg (2013) 1.39

Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Circulation (2003) 1.38

The Infant Aphakia Treatment Study: evaluation of cataract morphology in eyes with monocular cataracts. J AAPOS (2011) 1.32

Clinical outcome of confluent laser photoablation for retinopathy of prematurity. J AAPOS (2002) 1.32

Glaucoma-related adverse events in the Infant Aphakia Treatment Study: 1-year results. Arch Ophthalmol (2011) 1.25

High-resolution magnetic resonance imaging: an emerging tool for evaluating intracranial arterial disease. Stroke (2012) 1.23

Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol (2013) 1.23

Vitreous hemorrhage in children. Ophthalmology (2006) 1.21

Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial. Neuroimaging Clin N Am (2007) 1.20

Stimulant reduction intervention using dosed exercise (STRIDE) - CTN 0037: study protocol for a randomized controlled trial. Trials (2011) 1.19

Homonymous hemianopia in stroke. J Neuroophthalmol (2006) 1.17

Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable. Stroke (2003) 1.15

Vitamin D insufficiency in diabetic retinopathy. Endocr Pract (2012) 1.15

Prevalence and prognosis of coexistent asymptomatic intracranial stenosis. Stroke (2008) 1.14

Reducing backward masking through action game training. J Vis (2010) 1.12

Computer programs for the concordance correlation coefficient. Comput Methods Programs Biomed (2007) 1.11

Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke (2008) 1.11

Evaluation of the reliability of clinical staging of T2 N0 esophageal cancer: a review of the Society of Thoracic Surgeons database. Ann Thorac Surg (2013) 1.10

Intracranial pressure pulse morphological features improved detection of decreased cerebral blood flow. Physiol Meas (2010) 1.08

Collateral circulation in symptomatic intracranial atherosclerosis. J Cereb Blood Flow Metab (2010) 1.08

Intraplaque hemorrhage in symptomatic intracranial atherosclerotic disease. J Neuroimaging (2011) 1.07

Electronic Interventions for Alcohol Misuse and Alcohol Use Disorders: A Systematic Review. Ann Intern Med (2015) 1.06

Visual rehabilitation and outcomes for ectasia after corneal refractive surgery. J Cataract Refract Surg (2008) 1.05

Risk factors associated with severity and location of intracranial arterial stenosis. Stroke (2010) 1.05

Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis. Neurology (2006) 1.05

Incidence, outcomes, and risk factors for retreatment after wavefront-optimized ablations with PRK and LASIK. J Refract Surg (2009) 1.05

Axial elongation following cataract surgery during the first year of life in the infant Aphakia Treatment Study. Invest Ophthalmol Vis Sci (2012) 1.05

Consensus conference on intracranial atherosclerotic disease: rationale, methodology, and results. J Neuroimaging (2009) 1.04

Early stroke risk after transient ischemic attack among individuals with symptomatic intracranial artery stenosis. Arch Neurol (2008) 1.03

Predictability of intraocular lens calculation and early refractive status: the Infant Aphakia Treatment Study. Arch Ophthalmol (2012) 1.00

The handy eye chart: a new visual acuity test for use in children. Ophthalmology (2012) 1.00

Assessing individual agreement. J Biopharm Stat (2007) 0.99

Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Stroke (2003) 0.98

Racial differences in vascular risk factors and outcomes of patients with intracranial atherosclerotic arterial stenosis. Stroke (2008) 0.97

Trabeculectomy with antiproliferative agents in uveitic glaucoma. J Glaucoma (2002) 0.95

Signal intensity ratio as a novel measure of hemodynamic significance for intracranial atherosclerosis. Int J Stroke (2013) 0.94

Visual outcome following the reduction or cessation of patching therapy after early unilateral cataract surgery. Arch Ophthalmol (2008) 0.94

Comparison of concordance correlation coefficient and coefficient of individual agreement in assessing agreement. J Biopharm Stat (2007) 0.93

Outcomes of wavefront-optimized surface ablation. Ophthalmology (2007) 0.92

Advanced modality imaging evaluation in acute ischemic stroke may lead to delayed endovascular reperfusion therapy without improvement in clinical outcomes. J Neurointerv Surg (2012) 0.90